Protalix BioTherapeutics, Inc.
USD1.96
-0.03 (-1.51%)
CEO
Dror Bashan
IPO Date
1998-05-15
Sector
Healthcare
Industry
Biotechnology
Exchange
AMEX
Country
US
Open
$1.97
Prev. Close
$1.99
Day Low
$1.95
Day High
$1.99
52W Low
$1.32
52W High
$3.19
Market Cap
$0.16B
Volume
0.80M
| 56,000 |
| $1.81 |
| 19 Nov 2025 | Bar-Shalev Amos | director | S-Sale | Disposed | 168 | $1.87 |
| 4 Sept 2025 | Melincoff Gwen A | director | A-Award | Acquired | 7,500 | $0.00 |
| 4 Sept 2025 | Melincoff Gwen A | director | A-Award | Acquired | 15,000 | $1.64 |
| 4 Sept 2025 | Forster Eliot | director | A-Award | Acquired | 7,500 | $0.00 |
| 4 Sept 2025 | Forster Eliot | director | A-Award | Acquired | 15,000 | $1.64 |
| 4 Sept 2025 | Boudes Pol F | director | A-Award | Acquired | 7,500 | $0.00 |
| 4 Sept 2025 | Boudes Pol F | director | A-Award | Acquired | 15,000 | $1.64 |
| 4 Sept 2025 | Elze Christian | director | A-Award | Acquired | 7,500 | $0.00 |